Fabrinet (FN) holder plans Rule 144 sale of 22,451 shares

Fabrinet (FN) shareholder has filed a Form 144 to sell up to 22,451 ordinary shares.

Rhea-AI Filing Summary

Fabrinet (FN) shareholder has filed a Form 144 to sell up to 22,451 ordinary shares. The planned sale is to be executed through Citigroup Global Markets, Inc. on the NYSE around 11/26/2025, with an indicated aggregate market value of $10,123,604.92. These shares relate to restricted stock that vested on 11/26/2025 as compensation in the form of services rendered.

The notice also reports earlier activity: over the past three months, the same seller disposed of 9,513 ordinary shares for gross proceeds of $3,134,730.00. The filing states that the seller is not aware of any undisclosed material adverse information about Fabrinet’s current or prospective operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Fabrinet (FN)'s latest Form 144 filing disclose?

The Form 144 discloses that a Fabrinet shareholder plans to sell up to 22,451 ordinary shares on the NYSE under Rule 144, using Citigroup Global Markets, Inc. as broker.

How many Fabrinet (FN) shares are planned to be sold and what is their value?

The filing indicates a planned sale of 22,451 ordinary shares with an aggregate market value of $10,123,604.92.

When were the Fabrinet (FN) shares being sold under Form 144 acquired?

The 22,451 ordinary shares were acquired on 11/26/2025 through restricted stock vesting from Fabrinet in exchange for services rendered.

On which exchange will the Fabrinet (FN) shares be sold and through which broker?

The planned sales are to be made on the NYSE through Citigroup Global Markets, Inc., located at 390 Greenwich Street, New York, NY 10013.

What prior Fabrinet (FN) share sales are reported in the past three months?

The notice reports that 9,513 ordinary shares were sold on 08/27/2025, generating gross proceeds of $3,134,730.00.

How many Fabrinet (FN) shares are outstanding in this Form 144 disclosure?

The Form 144 lists 35,827,210 ordinary shares as outstanding at the time of the filing; this is a baseline figure for the company’s equity.

What representation does the seller make about Fabrinet (FN) in the Form 144?

By signing the notice, the seller represents that they do not know of any material adverse information about Fabrinet’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/26/2025 - 03:38 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001717718
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Fabrinet
SEC File Number	001-34775
Address of Issuer	C/O INTERTRUST CORPORATE SERVICES ONE NEXUS WAY, CAMANA BAY GRAND CAYMAN CAYMAN ISLANDS KY1-9005
Phone	(408) 748 0900
Name of Person for Whose Account the Securities are To Be Sold	Grady Seamus
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Chief Executive Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Citigroup Global Markets, Inc 390 Greenwich Street New York NY 10013	22451	10123604.92	35827210	11/26/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	11/26/2025	Restricted Stock Vesting	Fabrinet			22451	11/26/2025	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Seamus Grady One Nexus Way Camana Bay E9 KY1-9005	Ordinary shares	08/27/2025	9513	3134730.00

144: Remarks and Signature

Remarks
Date of Notice	11/26/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Conformed Signature On File
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)